Your session is about to expire
← Back to Search
SRD-001 for Heart Failure (MUSIC-HFrEF1 Trial)
MUSIC-HFrEF1 Trial Summary
This trial is testing whether or not fixing a protein that isn't working properly in the heart will help people with heart failure by improving cardiac contractile function (the heart's pumping action) and increasing blood flow.
MUSIC-HFrEF1 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMUSIC-HFrEF1 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MUSIC-HFrEF1 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have specific heart or thyroid conditions.My liver and kidney functions are not normal.I have had heart surgery or use a heart support device.I am on the best possible treatment for heart failure and have an ICD.I have a long-term heart muscle condition.I have a long-term heart muscle condition.I haven't had cancer in the last 5 years, except for skin cancer or early stage cancer that was surgically removed.I may need a heart transplant or a mechanical support device soon due to unstable heart function.I am following doctor-recommended treatments for heart failure.Your heart's pumping ability is very low.The term "ICD" typically refers to "International Classification of Diseases", a standard diagnostic tool used for epidemiology, health management, and clinical purposes. If you are referring to a specific criterion related to ICD, please provide more details so I can accurately summarize it for you.I am likely to undergo a heart-related surgery within 6 months after treatment.I have severe heart condition symptoms.
- Group 1: Placebo
- Group 2: SRD-001
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any remaining slots for participants in this experiment?
"Affirmative. Clinicaltrials.gov attests that this medical trial is actively seeking participants since its inception on December 1st, 2021 and most recent update on July 26th 2022. The study aims to involve 56 patients from one single site."
What are the ultimate objectives of this experiment?
"Sardocor Corp., the trial sponsor, aims to measure Change from baseline in LV function/remodeling over a 6-month and 12-month period. Additionally, they will be tracking secondary outcomes such as New arrhythmias on ECG results, variations in concomitant heart failure medication use, and any abnormalities found during hematologic tests or serum chemistries NT-proBNP troponin evaluations."
Who is eligible to enroll in the research project?
"This clinical investigation is looking for 56 individuals, aged 18 to 80 years old, who are currently suffering from systolic heart failure."
What is the highest number of participants that can be included in this experiment?
"Affirmative. Clinicaltrials.gov indicates that this research, initially published on December 1st 2021, is actively enrolling individuals in the experiment. 56 patients must be acquired from a single medical centre."
Is this clinical experiment enrolling individuals aged 45 or older?
"This research is open to individuals aged eighteen and above, but no more than eighty years old."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger